3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
41
Stomach Neoplasms
3
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Pleuropulmonary blastoma
1
Patient Preference
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
HER2-positive Breast Cancer
1
HER2 Positive Breast Cancer
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Advanced Unresectable or Metastatic Solid Malignancy
1
Interventions
fludarabine phosphate
28
Peripheral Blood Stem Cell Transplantation
25
Cyclophosphamide
24
Whole-Body Irradiation
22
Busulfan
22
Tacrolimus
19
Mycophenolic Acid
19
Methotrexate
15
Antilymphocyte Serum
13
Cyclosporine
12
Melphalan
9
Filgrastim
9
Cytarabine
9
Etoposide
8
Cord Blood Stem Cell Transplantation
7
fludarabine
6
Thiotepa
6
Methylprednisolone
6
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
thymoglobulin
4
merphos
4
Sirolimus
4
Rituximab
4
Radiotherapy
4
Flow Cytometry
4
Dexamethasone
4
Dasatinib
4
Cyclosporins
4
Calcium Dobesilate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Blast Crisis
×
Ado-Trastuzumab Emtansine
×
Clear all
No trials found.